Subscribe

Loss of CD20 Expression in B-Cell Malignant Lymphomas Associated with Rituximab Therapy

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

Monoclonal antibody against CD20 (rituximab) is used to treat patients with B-cell malignant lymphomas that express CD20. Sometimes a patient treated with lymphoma will develop a recurrence of lymphoma with CD20-negative cells.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone